⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

FHTX News

Foghorn Therapeutics Inc. Common Stock

Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit